Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 13;17(1):e0262123.
doi: 10.1371/journal.pone.0262123. eCollection 2022.

Diagnostic performance of oral swabs for non-sputum based TB diagnosis in a TB/HIV endemic setting

Sylvia M LaCourse  1   2 , Evans Seko  3 , Rachel Wood  4 , Wilfred Bundi  3 , Gregory S Ouma  3 , Janet Agaya  3 , Barbra A Richardson  2   5 , Grace John-Stewart  1   2   6   7 , Steve Wandiga  3 , Gerard A Cangelosi  2   4   6
Affiliations

Diagnostic performance of oral swabs for non-sputum based TB diagnosis in a TB/HIV endemic setting

Sylvia M LaCourse et al. PLoS One. .

Abstract

Objective: We evaluated diagnostic performance of oral swab analysis (OSA) for tuberculosis (TB) in a high HIV/TB burden setting in Kenya.

Methods: In this cross-sectional study, buccal swabs and sputum were collected from 100 participants with suspected TB in outpatient clinics in Kenya at enrollment and subsequent morning visits. Buccal swabs underwent IS6110-targeted qPCR analysis. Sputum was evaluated by Xpert MTB/RIF (Xpert) and culture. Diagnostic performance of OSA for TB diagnosis was evaluated relative to a combined reference of sputum Xpert and culture.

Results: Among 100 participants, 54% were living with HIV (PLHIV). Twenty percent (20/100) of participants had confirmed TB (19/20 [95%] culture-positive, 17/20 [85%] Xpert-positive). Overall buccal swab sensitivity was 65.0% (95% CI 40.8-84.6%) vs. sputum Xpert/culture and 76.5% (95% CI 50.1-93.2%) vs. sputum Xpert alone. Specificity was 81.3% (95% CI 71.0-89.1%) and 81.9% (95% CI 72.0-89.5%) compared to sputum Xpert/culture and Xpert alone, respectively. Sensitivity among PLHIV (n = 54) with suspected TB was 83.3% (95% CI 35.9-99.6%) vs. sputum Xpert/culture and 100% (95% CI 47.8-100.0%) vs. sputum Xpert alone. Among participants with TB, mean OSA threshold quantitation cycle (Cq) value was lower (stronger signal) at subsequent morning compared to enrolment visit (33.4 SD ± 3.7 vs. 35.2 SD ± 2.9, p = 0.009).

Conclusions: In this pilot study, results confirm M. tuberculosis DNA is detectable in oral swabs including among PLHIV with fair diagnostic performance. Further work is needed to optimize OSA and evaluate its utility in diverse settings.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study flow of participants evaluated for oral swab analysis (OSA) for TB diagnosis in western Kenya.
Visit 1 = enrollment, Visit 2 = subsequent morning. TB—tuberculosis, Mtb—Mycobacterium tuberculosis, Cx+—culture-positive.
See this image and copyright information in PMC

References

    1. Joint United Nations Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic 2015 Geneva, Switzerland: UNAIDS; 2015. [cited 2020 December 1]. Available from: http://www.unaids.org/en/resources/documents/2013/20130923_UNAIDS_Global....
    1. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children Geneva, Switzerland: World Health Organization; 2013. [cited 2020 December 15]. Available from: http://apps.who.int/iris/handle/10665/112472. - PubMed
    1. Horne DJ, Kohli M, Zifodya JS, Schiller I, Dendukuri N, Tollefson D, et al.. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019;6:CD009593. doi: 10.1002/14651858.CD009593.pub4 ; PubMed Central PMCID: PMC6555588. - DOI - PMC - PubMed
    1. Pai M, Schito M. Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects. J Infect Dis. 2015;211(suppl 2):S21–S8. doi: 10.1093/infdis/jiu803 ; PubMed Central PMCID: PMC4366576. - DOI - PMC - PubMed
    1. Wood RC, Luabeya AK, Weigel KM, Wilbur AK, Jones-Engel L, Hatherill M, et al.. Detection of Mycobacterium tuberculosis DNA on the oral mucosa of tuberculosis patients. Sci Rep. 2015;5:8668. doi: 10.1038/srep08668 ; PubMed Central PMCID: PMC4345328. - DOI - PMC - PubMed